Goldman Sachs
ELGX

Goldman Sachs’s Endologix Inc ELGX Stock Holding History

Goldman Sachs’s Portfolio ELGX Stock Details ELGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-260
Closed -$12K – 6858
2017
Q3 		$12K Hold
260
– – ﹤0.01% 6516
2017
Q2 		$13K Sell
260
-4,940
-95% -$291K ﹤0.01% 6629
2017
Q1 		$376K Hold
5,200
– – ﹤0.01% 5271
2016
Q4 		$297K Buy
+5,200
New +$476K ﹤0.01% 5491
2016
Q3 		– Sell
-110
Closed -$14K – 7299
2016
Q2 		$14K Buy
+110
New +$12.6K ﹤0.01% 6807
2016
Q1 		– Sell
-90
Closed -$9K – 7457
2015
Q4 		$9K Buy
+90
New +$9.65K ﹤0.01% 6989
2014
Q3 		– Sell
-14,500
Closed -$2.21M – 7360
2014
Q2 		$2.21M Buy
14,500
+12,220
+536% +$1.63M ﹤0.01% 3890
2014
Q1 		$293K Sell
2,280
-41,720
-95% -$6.49M ﹤0.01% 5760
2013
Q4 		$7.67M Buy
+44,000
New +$7.56M ﹤0.01% 2612

Other funds holding ELGX

ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AGA
Altrinsic Global Advisors Stamford, Connecticut $2.79B AUM 7.25% 1-Year Est. Return

Goldman Sachs's ELGX Position: Q3 2019 in Review

Goldman Sachs sold out of Endologix Inc (ELGX) in Q3 2019, closing a stake of 76,798 shares — an estimated $556K sold.

Goldman Sachs first reported a position in ELGX in Q2 2013 and held it in 25 quarters. The position peaked at $63.4M in Q1 2015. 63 funds tracked by Wall St. Rank hold ELGX as of Q3 2019.

  • Goldman Sachs reported no remaining Endologix Inc position as of Q3 2019 after selling out during the quarter.
  • Goldman Sachs sold 76,798 Endologix Inc shares in Q3 2019, an estimated $556K.
  • Goldman Sachs first reported a position in Endologix Inc in Q2 2013 and held it in 25 quarters.
  • Goldman Sachs's Endologix Inc position peaked at $63.4M in Q1 2015.
  • 63 funds tracked by Wall St. Rank held Endologix Inc as of Q3 2019.

Based on Goldman Sachs's 13F filing for Q3 2019, filed 14 Nov 2019.